JPWO2022230912A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022230912A5
JPWO2022230912A5 JP2023517579A JP2023517579A JPWO2022230912A5 JP WO2022230912 A5 JPWO2022230912 A5 JP WO2022230912A5 JP 2023517579 A JP2023517579 A JP 2023517579A JP 2023517579 A JP2023517579 A JP 2023517579A JP WO2022230912 A5 JPWO2022230912 A5 JP WO2022230912A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylene
different
cycloalkyl
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023517579A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2022230912A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2022/018994 external-priority patent/WO2022230912A1/ja
Publication of JPWO2022230912A1 publication Critical patent/JPWO2022230912A1/ja
Publication of JPWO2022230912A5 publication Critical patent/JPWO2022230912A5/ja
Pending legal-status Critical Current

Links

JP2023517579A 2021-04-28 2022-04-27 Pending JPWO2022230912A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021075905 2021-04-28
PCT/JP2022/018994 WO2022230912A1 (ja) 2021-04-28 2022-04-27 置換トリアジン化合物

Publications (2)

Publication Number Publication Date
JPWO2022230912A1 JPWO2022230912A1 (https=) 2022-11-03
JPWO2022230912A5 true JPWO2022230912A5 (https=) 2025-05-07

Family

ID=83848494

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023517579A Pending JPWO2022230912A1 (https=) 2021-04-28 2022-04-27

Country Status (11)

Country Link
US (1) US20240239758A1 (https=)
EP (1) EP4345097A4 (https=)
JP (1) JPWO2022230912A1 (https=)
KR (1) KR20240004371A (https=)
CN (1) CN117222626A (https=)
AU (1) AU2022267160A1 (https=)
BR (1) BR112023022451A2 (https=)
CA (1) CA3218212A1 (https=)
MX (1) MX2023012795A (https=)
TW (1) TW202309000A (https=)
WO (1) WO2022230912A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11618751B1 (en) 2022-03-25 2023-04-04 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 derivatives
US11319319B1 (en) 2021-04-07 2022-05-03 Ventus Therapeutics U.S., Inc. Compounds for inhibiting NLRP3 and uses thereof
TW202313577A (zh) 2021-06-04 2023-04-01 瑞士商赫孚孟拉羅股份公司 新穎化合物
LT4363406T (lt) 2021-07-02 2025-12-29 Astrazeneca Ab Nlrp3 inflamasomų inhibitoriai
WO2023066377A1 (zh) * 2021-10-22 2023-04-27 索智生物科技(浙江)有限公司 一种含氮化合物、其制备方法及应用
IL314025A (en) * 2022-01-07 2024-08-01 Transthera Sciences Nanjing Inc Nlrp3 inflammasome inhibitor and uses thereof
US12331048B2 (en) 2022-10-31 2025-06-17 Ventus Therapeutics U.S., Inc. Pyrido-[3,4-d]pyridazine amine derivatives useful as NLRP3 inhibitors
WO2024094150A1 (en) * 2022-11-04 2024-05-10 Insilico Medicine Ip Limited Nlrp3 inflammasome inhibitors and uses thereof
AU2023371859A1 (en) * 2022-11-04 2025-06-12 Transthera Sciences (Nanjing) , Inc. Nlrp3 inflammasome inhibitor and use thereof
CN120569372A (zh) * 2023-01-24 2025-08-29 第一三共株式会社 经取代的苯化合物
WO2024169858A1 (zh) * 2023-02-17 2024-08-22 成都赜灵生物医药科技有限公司 六元氮杂环类化合物及其用途
JP2026511027A (ja) * 2023-03-20 2026-04-10 インシリコ メディスン アイピー リミティド Nlrp3インフラマソーム阻害剤及びその使用
WO2024193699A1 (zh) * 2023-03-23 2024-09-26 成都赜灵生物医药科技有限公司 三嗪类化合物及其用途
KR20260027946A (ko) 2023-06-02 2026-03-03 머크 샤프 앤드 돔 엘엘씨 Nod-유사 수용체 단백질 3의 억제제로서 유용한 5,6 불포화 비시클릭 헤테로사이클
WO2025059069A1 (en) * 2023-09-12 2025-03-20 Zomagen Biosciences Ltd Nlrp3 modulators
WO2025153532A1 (en) 2024-01-16 2025-07-24 NodThera Limited Nlrp3 inhibitors and glp-1 agonists combination therapies
CN118440041B (zh) * 2024-07-02 2024-09-27 苏州凯瑞医药科技有限公司 一种手性4-氨基-3-羟基四氢吡喃的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
ES2940611T3 (es) 2016-04-18 2023-05-09 Novartis Ag Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad de NLRP
EP3272739A1 (en) 2016-07-20 2018-01-24 NodThera Limited Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
US11465992B2 (en) 2017-07-07 2022-10-11 Inflazome Limited Sulfonamide carboxamide compounds
MX2020009957A (es) 2018-03-27 2021-01-15 Ptc Therapeutics Inc Compuestos para el tratamiento de enfermedad de hungtinton.
WO2020163248A1 (en) 2019-02-04 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
AR119731A1 (es) * 2019-05-17 2022-01-05 Novartis Ag Inhibidores del inflamasoma nlrp3
CN115279739B (zh) 2020-03-27 2025-07-22 尼科治疗有限公司 取代哒嗪化合物
TW202313577A (zh) * 2021-06-04 2023-04-01 瑞士商赫孚孟拉羅股份公司 新穎化合物
WO2023066377A1 (zh) * 2021-10-22 2023-04-27 索智生物科技(浙江)有限公司 一种含氮化合物、其制备方法及应用

Similar Documents

Publication Publication Date Title
JPWO2022230912A5 (https=)
JPWO2023003002A5 (https=)
JP2009525287A5 (https=)
JP2008516986A5 (https=)
JP2023516381A5 (https=)
JP2005517006A5 (https=)
JP2017515844A5 (https=)
JP2006077019A5 (https=)
HRP20191821T1 (hr) Antiproliferativni spojevi i načini njihove uporabe
JP2013544276A5 (https=)
JP2009525340A5 (https=)
JP2018514544A5 (https=)
JP2016512558A5 (https=)
JP2009529059A5 (https=)
RU2013143028A (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
JP2016164184A5 (https=)
JP2005506308A5 (https=)
JP2016510038A5 (https=)
JP2008506720A5 (https=)
JP2010516700A5 (https=)
JP2018532698A5 (https=)
JP2010540462A5 (https=)
JP2014532754A5 (https=)
JP2014523400A (ja) 芳香族アミド類およびそれらの使用
JP2009501775A5 (https=)